Literature DB >> 7690807

Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.

L Adorini1, J C Guéry, S Fuchs, V Ortiz-Navarrete, G J Hämmerling, F Momburg.   

Abstract

To study the processing and presentation of endogenously synthesized Ag to class II MHC-restricted T cells, hen egg lysozyme (HEL), either tagged with a peptide that confers retention in the endoplasmic reticulum (HEL.KDEL), or in the secretory form (HELs), was stably expressed in LK-35.2 B hybridoma cells. Presentation of HEL peptides bound to class II molecules was assessed by activation of specific T cell hybridomas recognizing seven different epitopes derived from exogenous HEL. The presentation of endogenously synthesized HEL was not caused by reuptake of secreted of shed Ag. All the HEL epitopes examined were efficiently presented after processing of endogenous HEL by HELs-transfected LK-35.2 cells. Processing of HEL tagged with KDEL, however, gave rise to presentation of only six of the seven HEL epitopes. The epitope included in the HEL sequence 112-124 was not presented by HEL.KDEL-transfected B cells. In addition, two of the four T cell hybridomas recognizing HEL 116-129 together with I-Ak molecules were not activated by HEL.KDEL, and three other epitopes were presented with lower efficiency as compared with HELs. Thus, endogenously synthesized HEL in secretory form gives rise to a set of class II-binding epitopes indistinguishable from exogenous HEL, whereas endoplasmic reticulum-retained HEL generates a similar but not identical set of epitopes. The endosomal protease inhibitor leupeptin prevented presentation of the epitope 108-116, but not 46-61, both by HELs and HEL.KDEL transfected cells, indicating a requirement for endosomal processing in both cases. In addition, the presentation of peptides derived from endogenously synthesized, either secretory or endoplasmic reticulum-retained HEL, could be inhibited by lysosomotropic amines, further indicating that the intracellular route of class II molecules presenting peptides derived from endogenous Ag intersects the acidic endosomal compartment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690807

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.

Authors:  R Nisini; M Paroli; D Accapezzato; F Bonino; F Rosina; T Santantonio; F Sallusto; A Amoroso; M Houghton; V Barnaba
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.

Authors:  J Deussing; W Roth; P Saftig; C Peters; H L Ploegh; J A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

3.  Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction.

Authors:  V R Aluvihare; A A Khamlichi; G T Williams; L Adorini; M S Neuberger
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

4.  B cells extract and present immobilized antigen: implications for affinity discrimination.

Authors:  F D Batista; M S Neuberger
Journal:  EMBO J       Date:  2000-02-15       Impact factor: 11.598

5.  Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant.

Authors:  J C Guéry; F Ria; L Adorini
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

6.  Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism.

Authors:  J A Villadangos; R J Riese; C Peters; H A Chapman; H L Ploegh
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

7.  Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage.

Authors:  A Volkmann; T Barthlott; S Weiss; R Frank; B Stockinger
Journal:  J Exp Med       Date:  1998-09-21       Impact factor: 14.307

8.  Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy.

Authors:  Christopher Horton; Timothy J Davies; Priyoshi Lahiri; Patty Sachamitr; Paul J Fairchild
Journal:  Stem Cells       Date:  2019-10-31       Impact factor: 6.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.